Use and morbidity of venous access devices in patients with hemophilia

Journal of Intravenous Nursing

Volumn 21, Issue 2, 1998, Pages 70-75

  Geraghty, Susan ^a   Kleinert, Dorothy ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; DEVICE; FEMALE; HEMOPHILIA; HUMAN; IMPLANTABLE PORT SYSTEM; INCIDENCE; INFANT; INFECTIOUS COMPLICATION; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PUERTO RICO; QUESTIONNAIRE; UNITED STATES; VASCULAR ACCESS;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; HEMOPHILIA A; HUMANS; INFANT; INFECTION CONTROL; MORBIDITY; PUERTO RICO; QUESTIONNAIRES; UNITED STATES;

EID: 0031953355     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Shultz WH, Ware R, Filston HC, Kinney TR. Prolonged use of an implantable central venous access system in a child with severe hemophilia. J Pediatr 1989;114:100-1.
2. McWhirter WR, Gray L. Indwelling intravenous device in a young haemophiliac. Lancet 1988;2(8602) 9:99-100.
3. Ljung RCR, Lindgren A-C, Tengborn L, Petrini P. Issues in prophylaxis for young children in Sweden: the long-term feasibility of venous access. In: Prophylactic treatment of hemophilia A and B: current and future perspectives. New York: Science & Medicine, 1994:49-51.
4. Ljung R, Petrini P, Lindgren A-K, Berntorp E. Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia. Acta Paediatr 1992;81:918-20.
5. Lilleyman JS. Domiciliary desensitization therapy for young boys with haemophilia and factor VIII inhibitors. Br J Haematol 1994;86: 433-5.
6. Brincker H, Saeter G. Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy. Cancer 1986; 57:1124-9.
7. Becton DL, Kletzel M, Golladay ES, Hathaway G, Berry DH. An experience with an implanted port system in 66 children with cancer. Cancer 1988;61:376-8.
8. Shapiro ED, Wald ER, Nelson KA, Spiegelman KN. Broviac catheter-related bacteremia in oncology patients. Am J Dis Child 1982;136:679-81.
9. Shulman RJ, Rahman S, Mahoney D, Pokorny WJ, Bloss R. A totally implanted venous access system used in pediatric patients with cancer. J Clin Oncol 1987;5:137-40.
10. Gleeson NC, Fiorica JV, Mark JE, et al. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients. Gynecol Oncol 1993;51:372-6.
11. Wesenberg F, Flaatten H, Janssen CW Jr. Central venous catheter with subcutaneous injection port (PORT-A-CATH): 8 years clinical follow up with children. Pediatric Hematology and Oncology 1993;10:233-9.
12. Farr BM. Vascular catheter related infections in cancer patients. Surg Oncol Clin North Am 1995;4:493-503.
13. Blanchette VS, Al-Musa A, Stain AM, Filler RM, Ingram J. Central venous access catheters in children in haemophilia. Blood Coag Fibrinolysis 1996;7(suppl 1):539-44.
14. Hilgartner MW, Kleinert D. Morbidity of central lines in patients with coagulation deficiencies. Pediatr Res 1995;37:158A. Abstract 933.
15. Zappa SC, Johnson AG, Cochran CJ, Sanders DM, Buchanan GR. Implantable intravenous access devices in children with hemophilia. Arch Pediatr Adolesc Med 1994;148:327-30.
16. Sultan Y. Epidemiology of HIV infection in multitransfused hemophilic patients in France. French Study Group in Haemophilia. Nouv Rev Fran d Hematol 1987;29:211-4.
17. Camp-Sorrell D. Implantable ports. Everything you always wanted to know. Journal of Intravenous Nursing 1992;15:262-73.
18. Pegelow CH, Narvaez M, Toledano SR, Davis J, Oiticica C, Buckner D. Experience with a totally implantable venous device in children. Am J Dis Child 1986;140:69-71.
19. Vidler V. Use of Port-a-Caths in the management of pediatric haemophilia. Professional Nurse 1994;10:48-50.
20. Sheldon P, Bender M. High-technology in home care. An overview of intravenous therapy. Nurs Clin North Am 1994;29:507-19.
21. Scribner BH. Management of haemophilia with atrial catheter. N Engl J Med 1976;295:233.
22. Miser AW, Roach JE, Harmael RP Jr, Sayers MP, Miser JS. Insertion of a central venous catheter for long-term venous access in a child with severe hemophilia and recurrent intracranial hemorrhage. Clin Pediatr 1984;23:589.
23. Keung YK, Watkins K, Chen SC, Groshen S, Silberman H, Douer D. Comparative study of infectious complications of different types of chronic central venous access devices. Cancer 1994;73:2832-7.
24. Ragni MV, Hord JD, Blatt J. Central venous catheter infection in haemophiliacs undergoing prophylaxis or immune tolerance with clotting factor concentrate. Haemophilia 1997;3:90-5.
25. Decker MD, Edwards KM. Central venous catheter infections. Pediatr Clin North Am 1988;35:579-612.
26. Ingram J, Weitzman S, Greenberg ML, Parkin P, Filler R. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 1991;13:130-6.
27. Parish LC. Clarithromycin in the treatment of skin and skin structure infections: two multicenter studies. Int J Dermatol 1993;32: 528-32.
28. Mallory SB. Azithromycin compared with cephalexin in the treatment of skin and skin structure infections. Am J Med 1991; 91(suppl 3A):3A-36S-9S.
29. Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO. Hickman catheter infections in patients with malignancies. Medicine 1984;63:189-200.
30. Pittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995;155:1177-84.